Revelation Biosciences Inc (REVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,709 | 5,174 | 3,705 | 6,499 | 6,541 |
| TOTAL | $12,832 | $5,360 | $3,928 | $6,566 | $6,659 |
| Non-Current Assets | |||||
| PPE Net | 24 | 35 | 42 | 56 | 81 |
| TOTAL | $24 | $35 | $42 | $56 | $81 |
| Total Assets | $12,856 | $5,395 | $3,970 | $6,622 | $6,740 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,035 | 829 | 625 | 784 | 3,127 |
| Accrued Expenses | 819 | 740 | 464 | 1,128 | 934 |
| Other current liabilities | 0 | 1 | 1 | 2 | 5 |
| TOTAL | $1,855 | $1,569 | $1,090 | $1,914 | $4,067 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,855 | $1,569 | $1,090 | $1,914 | $4,067 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,481 | 425 | 80 | 75 | 22 |
| Common Shares | 4 | 2 | 1 | 0 | 4 |
| Retained earnings | -46,908 | -45,001 | -42,557 | -40,506 | -38,780 |
| TOTAL | $11,002 | $3,826 | $2,881 | $4,708 | $2,674 |
| Total Liabilities And Equity | $12,856 | $5,395 | $3,970 | $6,622 | $6,740 |